Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
COXFA4 pseudogene 4 (COXFA4P4) is classified as a pseudogene, meaning it is a DNA sequence similar to the functional COXFA4 (cytochrome c oxidase-associated subunit FA4) gene but is generally not translated into a functional protein[6]. COXFA4P4 does not encode any known protein product and is not recognized as a functional therapeutic target, enzyme, transporter, receptor, or signaling molecule. There is no evidence that COXFA4P4 serves as a drug target or biomarker, nor are there documented drugs that interact with it. In general, most pseudogenes do not have established functional roles; however, emerging research suggests some pseudogenes can exert regulatory influence on gene expression by acting as competitive endogenous RNAs or microRNA sponges[3]. This is not documented specifically for COXFA4P4. Currently, it is neither a therapeutic target nor linked directly to diseases.\n\nNotes and Rationale:\n- The naming, as provided, is correct for the pseudogene. However, pseudogenes like COXFA4P4 are generally not considered valid therapeutic targets because they lack protein-coding capacity and are not involved in receptor/enzyme/transporter activity[3][6]. Thus, entries related to targets, drug interactions, or disease roles are set to null.\n- If you intended to refer to the functional protein-coding gene (COXFA4), that gene is associated with cytochrome c oxidase and mitochondrial function, not the pseudogene[6]. If so, please specify, as COXFA4 would have a different structured profile.\n\nSummary Statement:\nCOXFA4 pseudogene 4 (COXFA4P4) is a human pseudogene with no recognized role as a therapeutic target or biological function beyond possible non-coding RNA regulatory potential. There is nothing incorrect about the name, but listing it as a target is not appropriate—hence, it is marked as *is_incorrect: true* for target-based applications[6][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on COXFA4 pseudogene 4 (COXFA4P4).